175.90
price down icon0.38%   -0.67
after-market アフターアワーズ: 175.90
loading
前日終値:
$176.57
開ける:
$176.3
24時間の取引高:
1.50M
Relative Volume:
1.19
時価総額:
$19.80B
収益:
$9.54B
当期純損益:
$841.00M
株価収益率:
23.64
EPS:
7.44
ネットキャッシュフロー:
$1.02B
1週間 パフォーマンス:
-0.80%
1か月 パフォーマンス:
+10.08%
6か月 パフォーマンス:
+10.37%
1年 パフォーマンス:
+29.21%
1日の値動き範囲:
Value
$175.80
$178.74
1週間の範囲:
Value
$175.25
$179.32
52週間の値動き範囲:
Value
$135.47
$179.32

Quest Diagnostics Inc Stock (DGX) Company Profile

Name
名前
Quest Diagnostics Inc
Name
セクター
Healthcare (1153)
Name
電話
(973) 520-2700
Name
住所
500 PLAZA DRIVE, SECAUCUS
Name
職員
56,000
Name
Twitter
@QuestDX
Name
次回の収益日
2025-04-22
Name
最新のSEC提出書
Name
DGX's Discussions on Twitter

DGX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Diagnostics & Research icon
DGX
Quest Diagnostics Inc
175.90 19.80B 9.54B 841.00M 1.02B 7.44
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
410.78 158.51B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
194.82 140.78B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
489.98 37.91B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
108.70 31.23B 6.53B 1.26B 1.31B 4.35
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
153.29 26.31B 15.41B 1.37B 2.11B 7.50

Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-04-02 開始されました Redburn Atlantic Buy
2025-03-04 ダウングレード Citigroup Buy → Neutral
2025-01-06 アップグレード Leerink Partners Market Perform → Outperform
2024-12-17 アップグレード Morgan Stanley Equal-Weight → Overweight
2024-12-10 再開されました Jefferies Buy
2024-10-23 アップグレード Robert W. Baird Neutral → Outperform
2024-08-28 再開されました Evercore ISI In-line
2024-07-10 アップグレード Citigroup Neutral → Buy
2024-02-26 開始されました Leerink Partners Market Perform
2024-02-07 アップグレード Jefferies Hold → Buy
2024-01-03 開始されました Barclays Equal Weight
2023-12-12 アップグレード BofA Securities Neutral → Buy
2023-06-29 開始されました Piper Sandler Neutral
2023-05-02 ダウングレード BofA Securities Buy → Neutral
2023-04-03 アップグレード Citigroup Sell → Neutral
2023-01-23 開始されました Evercore ISI In-line
2022-11-17 ダウングレード Citigroup Neutral → Sell
2022-08-22 再開されました Morgan Stanley Equal-Weight
2022-04-04 ダウングレード Citigroup Buy → Neutral
2022-02-23 ダウングレード UBS Buy → Neutral
2022-02-02 ダウングレード Jefferies Buy → Hold
2022-01-28 ダウングレード Deutsche Bank Buy → Hold
2021-05-04 アップグレード UBS Neutral → Buy
2021-03-12 ダウングレード Robert W. Baird Outperform → Neutral
2020-10-21 アップグレード Argus Hold → Buy
2020-07-29 アップグレード KeyBanc Capital Markets Sector Weight → Overweight
2020-07-14 アップグレード BofA Securities Neutral → Buy
2020-06-09 アップグレード Wells Fargo Underweight → Equal Weight
2020-06-02 アップグレード Deutsche Bank Hold → Buy
2020-04-28 アップグレード Morgan Stanley Equal-Weight → Overweight
2020-04-27 アップグレード Citigroup Neutral → Buy
2020-04-27 アップグレード Wolfe Research Underperform → Peer Perform
2020-03-27 ダウングレード Morgan Stanley Overweight → Equal-Weight
2020-01-08 開始されました Wells Fargo Underweight
2020-01-07 ダウングレード Barclays Overweight → Equal Weight
2019-12-19 アップグレード BofA/Merrill Underperform → Neutral
2019-07-15 ダウングレード Goldman Neutral → Sell
2019-04-02 アップグレード Jefferies Hold → Buy
2019-03-18 再開されました Credit Suisse Neutral
2019-01-31 ダウングレード Argus Buy → Hold
2019-01-17 開始されました UBS Neutral
2019-01-03 ダウングレード BofA/Merrill Neutral → Underperform
2018-12-03 ダウングレード BofA/Merrill Buy → Neutral
2018-11-30 ダウングレード Goldman Buy → Neutral
すべてを表示

Quest Diagnostics Inc (DGX) 最新ニュース

pulisher
May 08, 2025

Global Immunodiagnostics Market to Cross the USD 32 Billion by 2032 | DelveInsight - GlobeNewswire Inc.

May 08, 2025
pulisher
May 06, 2025

Nike To $70? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga

May 06, 2025
pulisher
May 06, 2025

Quest Diagnostics (DGX) Sees Raised Target Price by JP Morgan | - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Quest Diagnostics (DGX) Receives Price Target Increase from JPMo - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Take the Zacks Approach to Beat the Markets: ADMA Biologics, Limbach, Quest Diagnostics in Focus - MSN

May 06, 2025
pulisher
May 03, 2025

Quest Diagnostics Stock: A Leader But Waiting For Better Price (NYSE:DGX) - Seeking Alpha

May 03, 2025
pulisher
May 02, 2025

Quest Settles Fired Black Phlebotomist's Retaliation Suit - Law360

May 02, 2025
pulisher
Apr 28, 2025

Fitch elevates Quest Diagnostics’ rating to ’BBB+’ with stable outlook By Investing.com - Investing.com Canada

Apr 28, 2025
pulisher
Apr 28, 2025

Fitch elevates Quest Diagnostics’ rating to ’BBB+’ with stable outlook - Investing.com

Apr 28, 2025
pulisher
Apr 28, 2025

Piper Sandler Adjusts Price Target on Quest Diagnostics to $200 From $180, Maintains Neutral Rating - marketscreener.com

Apr 28, 2025
pulisher
Apr 26, 2025

Decoding Quest Diagnostics Inc (DGX): A Strategic SWOT Insight - GuruFocus

Apr 26, 2025
pulisher
Apr 24, 2025

Here's How Much You Would Have Made Owning Quest Diagnostics Stock In The Last 5 Years - Benzinga

Apr 24, 2025
pulisher
Apr 24, 2025

Truist Financial Keeps Their Hold Rating on Quest Diagnostics (DGX) - The Globe and Mail

Apr 24, 2025
pulisher
Apr 23, 2025

These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Q1 Earnings - Benzinga

Apr 23, 2025
pulisher
Apr 23, 2025

Morgan Stanley Adjusts Quest Diagnostics Price Target to $182 From $172, Maintains Overweight Rating - marketscreener.com

Apr 23, 2025
pulisher
Apr 23, 2025

Baird Adjusts Quest Diagnostics Price Target to $194 From $191, Maintains Outperform Rating - marketscreener.com

Apr 23, 2025
pulisher
Apr 23, 2025

Jefferies Adjusts Quest Diagnostics Price Target to $195 From $190, Maintains Buy Rating - marketscreener.com

Apr 23, 2025
pulisher
Apr 23, 2025

Quest Diagnostics (DGX) Sees Price Target Increase Following Str - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

Mizuho Securities Adjusts Quest Diagnostics Price Target to $190 From $189 - marketscreener.com

Apr 23, 2025
pulisher
Apr 23, 2025

Quest Diagnostics (DGX) Sees Price Target Increase Following Strong Q1 Results | DGX Stock News - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

A Glimpse Into The Expert Outlook On Quest Diagnostics Through 12 Analysts - Benzinga

Apr 23, 2025
pulisher
Apr 23, 2025

Quest Diagnostics Incorporated (NYSE:DGX) Q1 2025 Earnings Call Transcript - Insider Monkey

Apr 23, 2025
pulisher
Apr 23, 2025

Truist Raises Price Target on Quest Diagnostics to $190 From $182, Keeps Hold Rating - marketscreener.com

Apr 23, 2025
pulisher
Apr 23, 2025

Quest Diagnostics (DGX) Sees Price Target Boost from Barclays | - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

Quest Diagnostics (DGX) Sees Price Target Boost from Barclays | DGX Stock News - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

Quest Diagnostics (DGX) Stock Analysis: Unpacking the 5.32% Potential Upside for Investors - DirectorsTalk Interviews

Apr 23, 2025
pulisher
Apr 23, 2025

Quest Diagnostics Inc (DGX) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance

Apr 23, 2025
pulisher
Apr 23, 2025

Quest Diagnostics Inc (DGX) Q1 2025 Earnings Call Highlights: St - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

Quest Diagnostics Inc (DGX) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Innovations - GuruFocus

Apr 23, 2025
pulisher
Apr 22, 2025

Quest Diagnostics: Q1 Earnings Snapshot - CTPost

Apr 22, 2025
pulisher
Apr 22, 2025

Quest Diagnostics earnings bolstered by March rebound, sending stock up 3% - MSN

Apr 22, 2025
pulisher
Apr 22, 2025

Barclays Raises Quest Diagnostics' Price Target to $185 From $175 - marketscreener.com

Apr 22, 2025
pulisher
Apr 22, 2025

Evercore ISI Adjusts Quest Diagnostics Price Target to $180 From $175 - marketscreener.com

Apr 22, 2025
pulisher
Apr 22, 2025

Quest Diagnostics Inc (DGX) Trading 6.97% Higher on Apr 22 - GuruFocus

Apr 22, 2025
pulisher
Apr 22, 2025

Quest Diagnostics (DGX) Reports Strong Q1 2025 Revenue Growth - GuruFocus

Apr 22, 2025
pulisher
Apr 22, 2025

Leerink Adjusts Price Target on Quest Diagnostics to $189 From $184 - marketscreener.com

Apr 22, 2025
pulisher
Apr 22, 2025

Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook ConfidenceQuest Diagnostics (NYSE:DGX) - Benzinga

Apr 22, 2025
pulisher
Apr 22, 2025

Quest Diagnostics (DGX) Increases EPS Outlook After Strong Q1 Performance - GuruFocus

Apr 22, 2025
pulisher
Apr 22, 2025

Quest Diagnostics Q1 Earnings & Revenues Top Estimates, Stock Up - Nasdaq

Apr 22, 2025
pulisher
Apr 22, 2025

Quest Diagnostics up 8% following earnings beats, EPS guidance raise - Seeking Alpha

Apr 22, 2025
pulisher
Apr 22, 2025

Quest Diagnostics Posts Better-Than-Expected Earnings, Joins Pentair, 3M, Danaher And Other Big Stocks Moving Higher On TuesdayAkso Health (NASDAQ:AHG), Bitdeer Technologies (NASDAQ:BTDR) - Benzinga

Apr 22, 2025
pulisher
Apr 22, 2025

Quest Diagnostics Shines With Strong Profits And Revenue Growth - Finimize

Apr 22, 2025
pulisher
Apr 22, 2025

Quest Diagnostics Reports First Quarter 2025 Financial Results; Reaffirms Revenue and Adjusted Diluted EPS Guidance for Full Year 2025 - The Malaysian Reserve

Apr 22, 2025
pulisher
Apr 22, 2025

Quest Diagnostics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

Apr 22, 2025
pulisher
Apr 22, 2025

Quest Diagnostics’ Q1 Earnings Align With Wall Street Estimates: Retail’s In Wait-And-Watch Mode - MSN

Apr 22, 2025
pulisher
Apr 22, 2025

Quest Diagnostics (DGX) Q1 Earnings and Revenues Beat Estimates - Yahoo

Apr 22, 2025
pulisher
Apr 22, 2025

Quest beats quarterly profit estimates on strong demand for diagnostic tests - marketscreener.com

Apr 22, 2025
pulisher
Apr 22, 2025

Strong Q1 Revenue Performance by Quest Diagnostics (DGX) Exceeds Projections | DGX Stock News - GuruFocus

Apr 22, 2025
pulisher
Apr 22, 2025

Quest Diagnostics Inc (DGX) Q1 2025 Earnings: EPS of $1.94 Beats Estimate, Revenue Hits $2.65 Billion - GuruFocus

Apr 22, 2025
pulisher
Apr 22, 2025

Quest Diagnostics Q1 Adjusted Earnings, Revenue Increase; 2025 Adjusted Earnings Outlook Affirmed - marketscreener.com

Apr 22, 2025
pulisher
Apr 22, 2025

Quest Diagnostics (DGX) Beats Q1 Estimates, Adjusts FY25 Guidance - GuruFocus

Apr 22, 2025

Quest Diagnostics Inc (DGX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
diagnostics_research LH
$248.76
price up icon 1.16%
diagnostics_research WAT
$350.88
price up icon 1.57%
diagnostics_research MTD
$1,101.63
price up icon 1.58%
$162.57
price up icon 1.54%
diagnostics_research IQV
$153.29
price down icon 0.01%
大文字化:     |  ボリューム (24 時間):